This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Medicis Pharmaceutical Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Terrence Blaschke: Innovator in Cholesterol Treatment
Introduction
Terrence Blaschke is a notable inventor based in Stanford, California. He has made significant contributions to the field of medical science, particularly in the treatment of insulin resistance, diabetes, and prediabetes. His innovative approach has led to the development of a unique patent that addresses these critical health issues.
Latest Patents
Terrence Blaschke holds a patent titled "Use of Oxygenated Cholesterol Sulfates for Treating at Least One of Insulin Resistance, Diabetes, and Prediabetes." This patent represents a significant advancement in the treatment options available for these conditions. He has 1 patent to his name, showcasing his commitment to innovation in healthcare.
Career Highlights
Blaschke is currently associated with Medicis Pharmaceutical Corporation, where he continues to work on groundbreaking research and development. His role at the company allows him to collaborate with other experts in the field and contribute to the advancement of medical treatments.
Collaborations
Some of his notable coworkers include Shunlin Ren and WeiQi Lin. Their combined expertise enhances the research efforts at Medicis Pharmaceutical Corporation, fostering an environment of innovation and discovery.
Conclusion
Terrence Blaschke's work in the field of cholesterol treatment exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new treatment options for diabetes and related conditions.